Article

In-House Pharmacy Services Improve Patient Engagement

Service to dispense oral oncolytics to patients shows positive results, doctors say.

Service to dispense oral oncolytics to patients shows positive results, doctors say.

Utilizing the services of an in-house pharmacy through a community oncology practice can improve patient engagement, according to physicians presenting at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting and Expo, held from April 1 through April 4 in Tampa, Florida.

Angel Aslo, PharmD, pharmacy director at The Mark H. Zangmeister Center in Columbus, Ohio, and Ray Bailey, PharmD, pharmacy director at Florida Cancer Specialists, said use of an in-house pharmacy service to dispense oral oncolytics to their patients shows promising results and allows them to focus on creating a positive experience for patients with cancer. The program does come with challenges, however, due to the high cost for organizations to gain accreditation for specialty pharmacy dispensing, which the physicians said can run an estimated $70,000 to $80,000 through health care accrediting group URAC.

For more information about the use of in-house pharmacy services, click here to visit AJMC.com for coverage of the AMCP Expo.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards